PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer
Author
McCubrey, James A.
Subject
Date
2017-02-21
Citation:
APA:
McCubrey, James A.. (February 2017).
PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer.
Scientific Reports,
(43013. Retrieved from
http://hdl.handle.net/10342/9643
MLA:
McCubrey, James A..
"PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer". Scientific Reports.
. (43013.),
February 2017.
May 17, 2022.
http://hdl.handle.net/10342/9643.
Chicago:
McCubrey, James A.,
"PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer," Scientific Reports 7, no.
(February 2017),
http://hdl.handle.net/10342/9643 (accessed
May 17, 2022).
AMA:
McCubrey, James A..
PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer. Scientific Reports.
February 2017;
7()
43013. http://hdl.handle.net/10342/9643. Accessed
May 17, 2022.
Collections